title: [Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer].
abstract: A 71-year-old man with nausea and epigastralgia was referred to our hospital and was diagnosed with type 3 gastric cancer. Palliative resection was performed since radical surgery was impossible due to massive tumorous invasion to the retroperitoneum. Chemotherapy with TS-1 100 mg p.o. was started for the residual cancer lesions, with CDDP i.v. 50 mg added from the 3rd course. We did not find any remarkable side effects except for grade 1 loss of appetite. This chemotherapy was ended after the eighth course. The residual tumor did not disappear but did not grow, and a no change status was maintained for twelve months after the gastrectomy.
authors.affiliation: Dept. of Surgery, Fujita Health University, School of Medicine.
authors.forename: Wakana
authors.initials: W
authors.lastname: Sakai
authors.forename: Hiroki
authors.initials: H
authors.lastname: Imazu
authors.forename: Ikuo
authors.initials: I
authors.lastname: Yoshida
authors.forename: Shuhei
authors.initials: S
authors.lastname: Tonomura
authors.forename: Yasutomo
authors.initials: Y
authors.lastname: Nozoe
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Shigeru
authors.initials: S
authors.lastname: Hasegawa
authors.forename: Toshiki
authors.initials: T
authors.lastname: Matsubara
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Sakurai
authors.forename: Masahiro
authors.initials: M
authors.lastname: Ochiai
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005743:Gastrectomy; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D018365:Neoplasm, Residual; D010094:Oxonic Acid / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; D011725:Pyridines; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D002945:Cisplatin